(Q43550900)

24 November 2017

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

24 November 2017

0 references

1 reference

W de Boer

1

1 reference

24 November 2017

W Driessen

series ordinal

2

1 reference

24 November 2017

A Jansz

series ordinal

3

1 reference

24 November 2017

G Tytgat

series ordinal

4

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

24 November 2017

1 reference

24 November 2017

345

1 reference

24 November 2017

8953

1 reference

24 November 2017

817-820

1 reference

Helicobacter pylori: current status

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Metronidazole-resistant Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

Transmucosal penetration of bismuth particles in the human stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992962-2

7 January 2021

10.1016/S0140-6736(95)92962-2

Identifiers

DOI

1 reference

24 November 2017

1 reference